当前位置：
X-MOL 学术
›
Rapid Commun. Mass Spectrom.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease
Rapid Communications in Mass Spectrometry ( IF 2 ) Pub Date : 2020-01-15 , DOI: 10.1002/rcm.8595 Jadranka Miletić Vukajlović 1 , Dunja Drakulić 2 , Snežana Pejić 2 , Tihomir V. Ilić 3 , Aleksandra Stefanović 4 , Marijana Petković 5, 6 , Jürgen Schiller 7
Rapid Communications in Mass Spectrometry ( IF 2 ) Pub Date : 2020-01-15 , DOI: 10.1002/rcm.8595 Jadranka Miletić Vukajlović 1 , Dunja Drakulić 2 , Snežana Pejić 2 , Tihomir V. Ilić 3 , Aleksandra Stefanović 4 , Marijana Petković 5, 6 , Jürgen Schiller 7
Affiliation
Changes in lipid composition might be associated with the onset and progression of various neurodegenerative diseases. Herein, we investigated the changes in the plasma phosphatidylcholine (PC)/lysophosphatidylcholine (LPC) ratios in patients with Parkinson's disease (PD) in comparison with healthy subjects and their correlation with clinico‐pathological features.
中文翻译：
帕金森氏病患者血浆磷脂酰胆碱/溶血磷脂酰胆碱比率增加
脂质组成的变化可能与各种神经退行性疾病的发生和发展有关。本文中，我们调查了帕金森病（PD）患者与健康受试者相比血浆磷脂酰胆碱（PC）/溶血磷脂酰胆碱（LPC）比率的变化及其与临床病理特征的相关性。
更新日期：2020-01-15
中文翻译：
帕金森氏病患者血浆磷脂酰胆碱/溶血磷脂酰胆碱比率增加
脂质组成的变化可能与各种神经退行性疾病的发生和发展有关。本文中，我们调查了帕金森病（PD）患者与健康受试者相比血浆磷脂酰胆碱（PC）/溶血磷脂酰胆碱（LPC）比率的变化及其与临床病理特征的相关性。
京公网安备 11010802027423号